Idiopathic Orbital Inflammation: 诊断标准变化影响编码趋势
Idiopathic orbital inflammation: a changing disease or a changing label?
研究分析了美国电子健康记录中慢性眶炎症的发病率和编码趋势,发现随着诊断标准的变化,过去被称为眶假瘤的病例中有部分被重新分类为IgG4相关疾病。2016年至2025年间,共有79,584,041名成人参与研究,结果显示H05.11(眶内肉芽肿)的诊断比例有所增加。
Idiopathic orbital inflammation, formerly termed orbital pseudotumour, is a diagnosis of exclusion. Consensus criteria now call for biopsy of lesions outside the extraocular muscles [1], and some biopsies once labelled idiopathic meet criteria for IgG4-related disease [2], which gained classification criteria in 2019 [3]. Whether this is reflected in how orbital inflammation is recorded is unknown. We examined trends in the incidence and coding of chronic orbital inflammation in United States electronic health records.
We used the TriNetX US Collaborative Network (Supplementary Table S1). The cohort comprised 79,584,041 adults with a visit in 2016–2025. The Incidence and Prevalence function counted incident diagnoses per calendar year (1095-day lookback) for H05.1 (chronic inflammatory disorders of orbit) and its subcodes H05.10 (unspecified), H05.11 (granuloma of orbit) and H05.12 (orbital myositis). ICD-10-CM indexes orbital pseudotumour to H05.11, so we examined the share of subcode diagnoses coded H05.11. Because person-time ends when a record ends, H05.1 was also compared with orbital (H05.01) and periorbital (L03.213) cellulitis in the same population [4]. Annual change was estimated by quasi-likelihood regression. All estimates describe recorded diagnoses. Claude (Anthropic PBC, San Francisco, California, USA) assisted with tabulation, figure generation and language editing; all values were verified against platform exports.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 18 print issues and online access
251.40 € per year only 13.97 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
39,95 €
Prices may be subject to local taxes which are calculated during checkout
Data availability
All released platform outputs, the complete analysis settings, code lists, reconstructed denominators and the post-export analysis script are provided in the Supplementary Information. Access to the underlying network requires a TriNetX license.
References
Mombaerts I, Bilyk JR, Rose GE, McNab AA, Fay A, Dolman PJ, et al. Consensus on diagnostic criteria of idiopathic orbital inflammation using a modified Delphi approach. JAMA Ophthalmol. 2017;135:769–76.
Andrew NH, Sladden N, Kearney DJ, Selva D. An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD. Br J Ophthalmol. 2015;99:376–81.
Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020;79:77–87.
Rassen JA, Bartels DB, Schneeweiss S, Patrick AR, Murk W. Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases. Clin Epidemiol. 2018;11:1–15.
Wittenborn JS, Lee AY, Lundeen EA, Lamuda P, Saaddine J, Su GL, et al. Validity of administrative claims and electronic health registry data from a single practice for eye health surveillance. JAMA Ophthalmol. 2023;141:534–41.
Funding
This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Author information
Authors and Affiliations
Department of Ophthalmology, Hadassah–Hebrew University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
Itay Nitzan, Tehila Shlomov & Zvi Gur
Authors
- Itay Nitzan
- Tehila Shlomov
- Zvi Gur
Contributions
IN conceived the study, designed and ran the platform queries, performed the analysis, prepared the figure and wrote the first draft. TS contributed to study design and interpretation and revised the manuscript. ZG contributed to study design, supervised the work, validated the analysis and revised the manuscript; ZG is the guarantor. All authors approved the submitted version.
Corresponding author
Correspondence to Zvi Gur.
Ethics declarations
Competing interests
IN serves as a Section Editor for Eye and had no role in the editorial handling of this manuscript. TS and ZG declare no competing interests.
Ethics approval
A waiver of institutional review board review and of informed consent was granted in accordance with the policy of the Hadassah Medical Organization, Jerusalem, Israel, for studies that use only aggregated, de-identified data supplied by a federated research network and give investigators no access to identifiable information. The study does not constitute human subjects research under 45 CFR 46.102(e).
AI declarations
Claude (Anthropic PBC, San Francisco, California, USA), a large language model, was used for data tabulation, figure generation and language editing, as stated in the Methods. The authors specified every analytic decision, verified all numerical output against the platform exports and take full responsibility for the content. Claude does not meet authorship criteria and is not listed as an author.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Nitzan, I., Shlomov, T. & Gur, Z. Idiopathic orbital inflammation: a changing disease or a changing label?. Eye (2026). https://doi.org/10.1038/s41433-026-05035-6
Received: 29 September 2026
Revised: 16 October 2026
Accepted: 23 October 2026
Published: 19 November 2026
Version of record: 19 November 2026
DOI: https://doi.org/10.1038/s41433-026-05035-6
来源:Nature 健康护理主题 · nature.com